Browse our anti-LPAR3 (LPAR3) Antibodies

Full name:
anti-Lysophosphatidic Acid Receptor 3 Antibodies (LPAR3)
On www.antibodies-online.com are 83 Lysophosphatidic Acid Receptor 3 (LPAR3) Antibodies from 17 different suppliers available. Additionally we are shipping LPAR3 Kits (21) and LPAR3 Proteins (4) and many more products for this protein. A total of 117 LPAR3 products are currently listed.
Synonyms:
Edg-7, Edg7, GPCR, HOFNH30, LP-A3, lpA3, RP4-678I3
list all antibodies Gene Name GeneID UniProt
LPAR3 23566 Q9UBY5
LPAR3 65086 Q9EQ31
LPAR3 66025 Q8K5E0

Show all species

Show all synonyms

Most Popular Reactivities for anti-LPAR3 (LPAR3) Antibodies

Select your species and application

anti-Human LPAR3 Antibodies:

anti-Mouse (Murine) LPAR3 Antibodies:

anti-Rat (Rattus) LPAR3 Antibodies:

All available anti-LPAR3 Antibodies

Go to our pre-filtered search.

Top referenced anti-LPAR3 Antibodies

  1. Human Polyclonal LPAR3 Primary Antibody for IHC, IHC (p) - ABIN4331421 : Leve, Peres-Moreira, Binato, Abdelhay, Morgado-Díaz: LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways. in PLoS ONE 2015 (PubMed)

More Antibodies against LPAR3 Interaction Partners

Pig (Porcine) Lysophosphatidic Acid Receptor 3 (LPAR3) interaction partners

  1. EDG4 (show LPAR2 Antibodies) and EDG7 map to q2.1 of pig chromosome 2 (SSC2 (show ELOVL2 Antibodies)) and q2.6-3.2 of pig chromosome6 (SSC6), respectively

  2. EDG7 was regulated by pregnancy stage and status. EDG7 expression was highest on d 12 pregnancy, and localized to the luminal and glandular epithelium, and EDG7 mRNA levels were elevated by estrogen in the endometrium.

Human Lysophosphatidic Acid Receptor 3 (LPAR3) interaction partners

  1. Expression profiles reveal LPAR3 (lysophosphatidic acid receptor 3) as a mediator for mitotic phosphorylation-driven pancreatic cell motility and invasion. Together, this work identifies YAP (show YAP1 Antibodies) as a novel regulator of pancreatic cancer cell motility, invasion and metastasis.

  2. These data indicated that the expression of LPA receptor 3 was increased in human triple-negative breast cancers and is associated with tumor metastatic ability.

  3. Suggest that LPA2 (show LPAR2 Antibodies) and LPA3 may function as a molecular switch and play opposing roles during megakaryopoiesis of K562 cells.

  4. The results demonstrate LPA (show APOA Antibodies)-stimulated migration in oral carcinoma cells through LPAR3, mediated further by PKC (show PRRT2 Antibodies), which acts either in concert with or independently of EGFR (show EGFR Antibodies) transactivation

  5. Findings indicate lysophosphatidic acid (LPA (show APOA Antibodies))-lysophosphatidic acid receptor-Galpha13 (show GNA13 Antibodies) signaling node as a therapeutic target for pancreatic cancer treatment and control.

  6. LPA3 mRNA is clearly expressed in human PANC-1 tumor cells.

  7. Lysophosphatidic acid (LPA) increased hepatocellular carcinoma cells cell invasion, which was LPA-receptor dependent.

  8. in the normal human menstrual cycle, lysophosphatidic acid receptor 3 messenger RNA and protein expression change, indicating that this gene may be related to the function of the endometrium.

  9. The results indicated that LPA(3) acts as a positive regulator of cell motility and invasion in sarcoma cells, suggesting that LPA (show APOA Antibodies) signaling pathway via LPA(3) may be involved in the progression of sarcoma cells.

  10. High LPAR3 expression is associated with aggressiveness of breast carcinoma.

Mouse (Murine) Lysophosphatidic Acid Receptor 3 (LPAR3) interaction partners

  1. These results indicate that ATX (show ENPP2 Antibodies)-lysophosphatidic acid-LPA3 signaling at the embryo-epithelial boundary induces decidualization via the canonical HB-EGF (show HBEGF Antibodies) and COX-2 (show COX2 Antibodies) pathways.

  2. Lpar3(-/-) female mice had delayed embryo implantation.

  3. These results suggest that LPA3 receptor-mediated amplification of spinal LPA production is required for the development of paclitaxel-induced neuropathic pain.

  4. These results suggest that LPA signaling through LPA3 may inhibit angiogenesis and fibroblast activation in mouse lung cancer cells

  5. The thromboxane A(2) receptor agonist 11-deoxy PGF (show PTGFR Antibodies)(2alpha) can partially alleviate embryo crowding in the Lpar3((-/-)) females and embryo crowding likely contributes to reduced litter size in the Lpar3((-/-)) females.

  6. Lysophosphatidic acid, via LPA(1 (show LPAR1 Antibodies)) and LPA(3) receptors, may play a significant role in inducing and/or sustaining the massive infiltration of leukocytes during inflammation

  7. Luminal epithelium localization and up-regulation by progesterone differentiate LPA3 from the other nine LP receptors and may underlie its essential role in embryo implantation.

  8. LPA(1 (show LPAR1 Antibodies)-3) are differentially expressed in the central nervous system and their expression is upregulated in response to injury.

  9. Lysophosphatidic acid receptors LPA3 and LPA1 (show LPAR1 Antibodies) promote CXCL12 (show CXCL12 Antibodies)-mediated smooth muscle progenitor cell recruitment.

  10. LPA3 receptor-mediated signalling has an influence on embryo implantation, and there is a linkage between LPA signalling and prostaglandin biosynthesis.

LPAR3 Antigen Profile

Antigen Summary

This gene encodes a member of the G protein-coupled receptor family, as well as the EDG family of proteins. This protein functions as a cellular receptor for lysophosphatidic acid and mediates lysophosphatidic acid-evoked calcium mobilization. This receptor couples predominantly to G(q/11) alpha proteins.

Alternative names and synonyms associated with LPAR3

  • lysophosphatidic acid receptor 3 (LPAR3) antibody
  • lysophosphatidic acid receptor 3 (LOC100038016) antibody
  • lysophosphatidic acid receptor 3 (Lpar3) antibody
  • Edg-7 antibody
  • Edg7 antibody
  • GPCR antibody
  • HOFNH30 antibody
  • LP-A3 antibody
  • lpA3 antibody
  • RP4-678I3 antibody

Protein level used designations for LPAR3

endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 7 , lysophosphatidic acid receptor 3 , LPA receptor 3 , LPA receptor EDG7 , LPA-3 , calcium-mobilizing lysophosphatidic acid receptor LP-A3 , endothelial cell differentiation gene 7 , lysophosphatidic acid receptor Edg-7 , endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor 7 , putative G protein-coupled receptor snGPCR32 , snGPCR32

GENE ID SPECIES
532829 Bos taurus
490187 Canis lupus familiaris
710828 Macaca mulatta
736110 Pan troglodytes
771215 Gallus gallus
100038016 Sus scrofa
100113360 Sus scrofa
100448001 Pongo abelii
23566 Homo sapiens
65086 Mus musculus
66025 Rattus norvegicus
Selected quality suppliers for anti-LPAR3 (LPAR3) Antibodies
Did you look for something else?